Synopsis
Russia's Federal Medical Biological Agency (FMBA) has announced the successful completion of preclinical trials for its cancer vaccine, demonstrating safety and high efficacy. The vaccine, initially targeting colorectal cancer, showed significant reductions in tumor size and improved survival rates. Further advancements are being made in developing vaccines for glioblastoma and melanoma.Russia's cancer vaccine has successfully completed preclinical trials, demonstrating both safety and high efficacy, Veronika Skvortsova, head of the Federal Medical and Biological Agency (FMBA), announced at the Eastern Economic Forum (EEF), Tass reported.
The initial target for this vaccine will be colorectal cancer. Moreover, promising progress has been made in developing vaccines for glioblastoma and specific types of melanoma, including ocular melanoma, which are currently at advanced stages of development.
Cancer vaccines are substances made in the lab that are used to make the body's natural defence mechanisms stronger to protect itself. Depending on the type of vaccine, some can be used as a cancer treatment, while others are used for cancer prevention (such as the human papillomavirus, or HPV, vaccine).
https://yourss365.blogspot.com/p/terms.html
----------------- Original Post ---------------
nstagram.com
metroindia.net
economictimes.indiatimes.com
P&S Intelligence @pnsintelligence BREAKING: Russia unveils cancer vaccine, ready for use and FREE for all patients! A game-changer in healthcare?
Posts
